Differences in rhodamine-123 efflux in B-type chronic lymphocytic leukemia suggest possible gender and stage variations in drug-resistance gene activity

Annals of Hematology

Volumn 76, Issue 5, 1998, Pages 189-194

  Steiner, H ^a,b   Polliack, A ^a   Kimchi Sarfaty, C ^a   Libster, D ^a   Fibach, E ^a   Rund, D ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Chronic lymphocytic leukemia; Drug resistance; MDR1; Multidrug resistance; Prognosis; Sex

Indexed keywords

GLYCOPROTEIN P; MONOCLONAL ANTIBODY; RHODAMINE 123;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; DRUG TRANSPORT; FEMALE; GENDER; GENE; GENE ACTIVITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; COLORING AGENTS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENES, MDR; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; NEOPLASM STAGING; P-GLYCOPROTEIN; PHENOTYPE; RHODAMINE 123; RHODAMINES; SEX CHARACTERISTICS; TIME FACTORS;

EID: 0031812725     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050387     Document Type: Article

References (33)

1. Arai Y, Masuda M, Sugawara I, Arai T, Motoji T, Tsuruo T, Oshimi K, Mizoguchi H (1997) Expression of the MDR1 and MDR3 gene products in acute and chronic leukemias. Leuk Res 21:313-319
2. Beck J, Niethammer D, Gekeler V (1994) High mdr1- and mrp- but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukemias. Cancer Lett 86:135-142
3. Beck W, Grogan T, Williams C, Cordon-Cardo C, Parham D, Kuttesch J, Andreef M, Bates S, Berard C, Boyett J, Brophy N, Broxterman H, Chan H, Dalton W, Dietel M, Fojo A, Gascoyne R, Head D, Houghton P, Srivastava D, Lehnert M, Leith C, Paietta E, Pavelic Z, Rimsza L, Roninson I, Sikic B, Twentyman P, Warnke R, Weinstein R (1996) Methods to detect P-glycoprotein-associated resistance in patients' tumors: consensus recommendations. Cancer Res 56:3010-3020
4. Broxterman H, Lankelman J, Pinedo H, Eekman C, Wahrer D, Ossenkoppele G, Schuurhuis G (1997) Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leúkemia. Leukemia 11:1110-1118
5. Catovsky D, Fooks J, Richard S (1989) Prognostic factors in chronic lymphocytic leukemia: the importance of age, sex and response to disease in survival. Br J Haematol 72:141-149
6. Chaudhary P, Roninson I (1991) Expression and activity of P-glycoprotein. a multidrug efflux pump, in human hemato-poietic stem cells. Cell 80:2735-2739
7. Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H, Andreef M (1992) Subpopulations of normal peripheral blood and hone marrow cells express a functional multi-drug resistant phenotype. Blood 80:2729-2734
8. Gekeler V, Frese G, Noller A, Handgretinger R, Willisch A, Schmidt H, Muller C, Dopfer R, Klingbiel T, Diddens H (1992) Mdrl/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukemias. Br J Cancer 66:507-517
9. Hamada H, Tsuruo T (1986) Functional role for the 170- 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 83:7785-7789
10. Hart S. Ganeshaguru K, Prentice H, Hoffbrand A, Mehta A (1996) Multidrug resistance (MDR1) expression and function is increased in advanced chronic lymphocytic leukemia (CLL). Blood 88 [Suppl]:363a
11. Herweijer H, Sonneveld P, Bass F, Nooter K (1990) Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J Natl Cancer Inst 82:1133-1140
12. Holmes J, Jacobs A, Carter G, Whittaker J, Bentley D, Padua R (1990) Is the mdr1 gene relevant in chronic lymphocytic leukemia? Leukemia 4:216-218
13. Inghirami G, Wieczorek R, Zhu B-J, Silber R, Dalla-Favera R, Knowles D (1988) Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia. Blood 72:1431-1434
14. Ivy S, Olshevski R, Taylor B, Patel K, Reaman G (1996) Correlation of P-glycoprotein expression and function in childhood acute leukemia. Blood 88:309-318
15. Leith C, Chen I, Kopecky K, Appelbaum F, Head D, Godwin J, Weick J, Willman C (1995) Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases. Blood 86:2329-2342
16. Ludescher C, Hilbe W, Eisterer W, Preuss E, Huber C, Gotwald M, Hofmann J, Thaler J (1993) Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay. J Natl Cancer Inst 85:1751-1758
17. Matutes E, Catovsky D (1991) The classification of the lymphoid leukemias. Leukemia Lymphoma 7 [Suppl]:153-155
18. Melo N, Hobday C, Dowsett M, Catovsky D, Matutes E, Morilla R, Polliack A (1990) Oestrogen receptor analysis in B-cell chronic lymphocytic leukemia: correlation of biochemical and immunological methods. Leuk Res 14:949-952
19. Michieli M, Raspadori D, Damiani D, Geromin A, Gallizia C, Michelutti A, Fanin R, Fasola G, Russo D, Tazzari P, Mallardi F, Baccarani M (1991) The expression of the multidrug resistance associated glycoprotein in B-cell chronic lymphocytic leukemia. Br J Haematol 77:460-465
20. Nuessler V, Gullis E, Pelka-Fleischer R, del Valle F, Diem H, Beyerlein S, Zwierzina H, Wilmanns W (1997) Expression and functional activity of P-glycoprotein in adult acute myelogenous leukemia patients. Ann Hematol 75:17-26
21. Pall G, Spitaler M, Gofman J, Thaler J, Ludescher C (1997) Multidrug resistance in leukemia: a comparison of different diagnostic methods. Leukemia 11:1067-1072
22. Piekarz R, Cohen D, Horwitz S (1993) Progesterone regulates the murine multidrug resistance mdr1b gene. J Biol Chem 268:7613-7616
23. Rabinowitz R, Polliack A, Leizerowitz R, Keren-Zur Y, Schlessinger M (1991) Expression of CD11a (LFA-1) on B-chronic lymphocytic leukemia and lymphoma cells: correlation with cell surface immunoglobulin intensity and CD58 (LFA-3) expression. Leukemia Lymphoma 7 [Suppl]:59-64
24. Ribrag V, Massade L, Faussat A, Dreyfus F, Bayle C, Gouyette A, Marie J (1996) Drug resistance mechanisms in chronic lymphocytic leukemia. Leukemia 10:1944-1949
25. Rochlitz C, de Kant E, Neubauer A, Heide I, Bohmer R, Oertel J, Huhn D, Herrmann R (1992) PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemia. Ann Hematol 65:241-246
26. Rund D, Fibach E, Polliack A (1994) High frequency and stability of multidrug resistance (MDR1) phenotype in chronic lymphocytic leukemia (CLL) versus B-cell and high-grade non-Hodgkin's lymphoma: functional assessment usina rhodamine 123. Blood 84:451a
27. Schuetz E, Furuya K, Schuetz J (1995) Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther 275:1011-1018
28. Shustik C, Groulx N, Gros P (1991) Analysis of multidrug resistance (MDR1) gene expression in chronic lymphocytic leukemia (CLL). Br J Haematol 79:50-56
29. Wall D, El-Osta S, Tzelepis D, Bertoncello I, Kantharides P, Chou S, Zalcberg J, Parkin J (1997) Expression of mdr1 and mrp in the normal B-cell homologue of B-cell chronic lymphocytic leukemia. Br J Haematol 96:697-707
30. Webb M, Raphael C, Asbahr H, Erber W, Meyer B (1996) The detection of rhodamine 123 drug efflux at low levels of drug resistance. Br J Haematol 93:650-655
31. Wilson C, Mrose S, Thomas D (1995) Enhanced production of B lymphocytes after castration. Blood 85:1535-1539
32. Wulf G, Kluding H, Ho A, Doerner M, Doehner H, Manegold C, Hunstein W (1994) Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis. Leuk Res 18:475-484
33. Young I (1977) Proof without prejudice: use of Kolmgorov-Smirnov test for the analysis of histograms from flow systems and other sources. J Histochem Cytochem 25:935-941